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Background: Several small, uncontrolled studies have found improvements in self-care behaviors and reductions in
clinical risk in persons with type 2 diabetes who received care from licensed naturopathic physicians. To extend
these findings and determine the feasibility and promise of a randomized clinical trial, we conducted a prospective
study to measure the effects of adjunctive naturopathic care (ANC) in primary care patients with inadequately
controlled type 2 diabetes.
Methods: Forty patients with type 2 diabetes were invited from a large integrated health care system to receive up
to eight ANC visits for up to one year. Participants were required to have hemoglobin A1c (HbA1c) values between
7.5-9.5 % and at least one additional cardiovascular risk factor (i.e., hypertension, hyperlipidemia or overweight).
Standardized instruments were administered by telephone to collect outcome data on self-care, self-efficacy,
diabetes problem areas, perceived stress, motivation, and mood. Changes from baseline scores were calculated at
6- and 12-months after entry into the study. Six and 12-month changes in clinical risk factors (i.e., HbA1c, lipid and
blood pressure) were calculated for the ANC cohort, and compared to changes in a cohort of 329 eligible,
non-participating patients constructed using electronic medical records data. Between-cohort comparisons were
adjusted for age, gender, baseline HbA1c, and diabetes medications. Six months was pre-specified as the primary
endpoint for outcome assessment.
Results: Participants made 3.9 ANC visits on average during the year, 78 % of which occurred within six months of
entry into the study. At 6-months, significant improvements were found in most patient-reported measures,
including glucose testing (P = 0.001), diet (P = 0.001), physical activity (P = 0.02), mood (P = 0.001), self-efficacy
(P = 0.0001) and motivation to change lifestyle (P = 0.003). Improvements in glucose testing, mood, self-efficacy and
motivation to change lifestyle persisted at 12-months (all P< 0.005). For clinical outcomes, mean HbA1c decreased
by −0.90 % (P = 0.02) in the ANC cohort at 6-months, a −0.51 % mean difference compared to usual care (P = 0.07).
Reductions at 12-months were not statistically significant (−0.34 % in the ANC cohort, P = 0.14; -0.37 % difference
compared to the usual care cohort, P = 0.12).
Conclusions: Improvements were noted in self-monitoring of glucose, diet, self-efficacy, motivation and mood
following initiation of ANC for patients with inadequately controlled type 2 diabetes. Study participants also
experienced reductions in blood glucose that exceeded those for similar patients who did not receive ANC.
Randomized clinical trials will be necessary to determine if ANC was responsible for these benefits.* Correspondence: cherkin.d@ghc.org
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The use of complementary and alternative medicine
(CAM) by people with type 2 diabetes exceeds that for
the general population, with estimates of use as high as
72 % (excluding solitary prayer) [1-5]. Although the use
of CAM in this population is high, little is known about
the effectiveness of CAM practices on diabetes-related
outcomes. For this reason, the Institute of Medicine has
included comparative effectiveness research (CER) of
CAM practices as a priority [6].
Care provided by naturopathic doctors (ND) is a par-
ticularly promising form of CAM practice for diabetes,
because the ND training emphasizes assessment and
understanding of medical risk, intensive dietary and life-
style counseling, and the routine laboratory testing and
medication prescribing necessary for ongoing manage-
ment [7-10]. Although randomized, controlled trials are
lacking, the findings from several small studies suggest
elements of ND care may lead to improved cardiometa-
bolic health in persons with type 2 diabetes. A small, un-
controlled 3-month clinical trial of ND approaches to
nutrition counseling for type 2 diabetes demonstrated
statistically significant reductions in hemoglobin A1c
(HbA1c), and several concurrent improvements in self-care,
including improved dietary adherence and improved eating
behaviors [10]. Retrospective observational studies also sug-
gest ND care reduces risk for type 2 diabetes and hyperten-
sion, including improved glucose control and reduced
blood pressure, respectively [7,8]. Because recent ancillary
analyses from the National Health Interview Survey (NHIS)
data suggest 13 % of visits to NDs were for type 2 diabetes
[11], further research is warranted to evaluate the safety
and effectiveness of ND practices in diabetes.
Prior to performing a randomized clinical trial of ND
approaches to care in type 2 diabetes, several research
gaps had to be filled, including the collection of data on
the acceptability and safety of ND practices, prospective
evidence of improved outcomes, and whether the effects
seemed generalizable. To fill these gaps, we conducted a
one-year prospective study of ND care provided as an
adjunct to usual care, i.e., adjunctive naturopathic care
(ANC), delivered to primary care patients with inad-
equately controlled type 2 diabetes recruited from a
managed care setting. We were particularly interested if
the emphasis on behavioral counseling reported in past
research of ND care would be evident in our study, if the
receipt of behavior change recommendations would
translate into improvements in patients’ behavior and/or
motivation to change behavior during the observation
period, and if any commensurate changes in clinical risk
would be evident. In this manuscript, we report the
results, including a summary of the treatment recom-
mendations delivered by NDs, the changes in patient-
reported outcome measures and standard clinical measures;and participants’ use of routine medical services during the
observation year.
Methods
Overview of study design
We conducted a one year observational cohort study of
persons with type 2 diabetes who were invited to receive
up to 8 visits of adjunctive naturopathic care (ANC). Un-
like an explanatory clinical trial with a defined protocol,
in this pragmatic observational study we left the number
and timing of visits, as well as the specific content of visits
to the discretion of the ANC providers. Our outcome mea-
sures included both changes in patient-reported outcomes
(PROs) and clinical laboratory risk measures, e.g., HbA1c,
blood pressure, and lipids, evaluated at six month intervals
during and following exposure to ND care as a whole dis-
cipline. All elements of the study were reviewed and
approved by the Group Health Institutional Review Board.
Study population
All participants were patients at Group Health (GH), a
large non-profit, integrated health care system based in
Seattle, WA who were not seeking ND care nor had
prior experience with ND care. Our goal was to enroll
40 participants aged 21–65 years with type 2 diabetes
who had the potential for meaningful improvement in
clinical risk factors. We therefore recruited individuals
who had a HbA1c between 7.5-9.5 % over the past year
and who had at least one additional cardiovascular risk
factor, i.e., those with elevated lipids (i.e., LDL> 100 mg/dl,
HDL <35 mg/dl for men or <45 mg/dl for women, and/or
triglycerides >150 mg/dl), high blood pressure (≥140/
90 mmHg) and/or those who were overweight (BMI> 25).
Because GH’s electronic health record (EHR) includes data
on age, gender, clinical diagnoses, laboratory results, and
dispensed medications (i.e., drug names, date of prescrip-
tions, and refills) we were able to exclude patients who did
not have lab values within our target ranges and others
who were inappropriate for participation, including those
who had a myocardial infarction or stroke within the past
six months, a recent history of bariatric surgery, a diagnosis
of severe psychiatric illness, (i.e., schizophrenia or per-
sonality disorder) and/or a diagnosis of cancer (except
non-melanoma skin cancer). We also excluded patients
taking insulin to reduce the variability in our small
sample.
Participant recruitment procedures for the ANC cohort
Patients meeting our inclusion criteria were mailed a
letter explaining the study and a postcard to return if
they had interest in participating. A research specialist
contacted candidates who returned the postcard and those
who remained interested and consented to participate
were given instructions to complete a laboratory test to
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dates confirmed to be eligible based on HbA1c testing
were enrolled and administered a baseline telephone
interview.
Creation of the usual care cohort
Electronic health record (EHR) data collected from a co-
hort of patients who continued to obtain their usual GH
care was used for comparing clinical outcome measures.
Patients in this group had baseline EHR data comparable
to those in the ANC group, and thus were potentially eli-
gible to receive the ANC intervention, but they were not
invited to participate. The only other known difference
between the cohorts is that many of patients in the usual
care cohort resided further from Seattle that those
recruited to the ANC cohort.
Recruitment of naturopathic doctors (ND), delivery of
ANC, collection of data to describe treatment
We selected four naturopathic doctors (ND) licensed in
WA State who had been practicing in the community for
at least five years and did not have specialty practices.
The NDs were instructed to deliver their typical care to
participants. Study participants were given a choice of
ND practice location to receive their care and provided
with the necessary information to schedule their first ap-
pointment. Completing the first visit was left to each
participant’s motivation and the number and timing of
follow-up visits was decided between the ND and the
participant. Following all of the ANC visits, a research
specialist abstracted data from the chart notes using a
standardized data collection form.
Collection of patient-reported outcomes (PROs) data
PROs data were collected over telephone interviews
upon enrollment and again after 6- and 12-months. Data
on demographics and medical history, including year of
diabetes diagnosis and history of heart failure, heart
attack, stroke, and/or micro-vascular complications
including neuropathy, retinopathy, cataracts, and/or
nephropathy were collected at baseline. We used the
Summary of Diabetes Self-Care Activities (SDSCA) in-
strument to measure diabetes self-care, which captures
the number of days in the past week patients engaged in
a variety of important self-care activities (e.g., checking
glucose, regular physical activity, eating fruits and vege-
tables, and taking medications as recommended) [12].
Mood and depression were assessed using the PHQ-8
[13,14]. The 16-question Self-Efficacy Scale (SES) [15,16]
was used to assess participant self-efficacy. Each question
on the SES was scored on a 0–8 Likert scale with
0 = “Not at all confident” and 8 = “Extremely confident”.
Responses to each question were combined to calculate
a single composite score [17]. We measured motivationfor changing self-care with the Readiness Index (RI) [18],
a nine-question instrument that uses a Likert scale ran-
ging from 1 (“Strongly disagree”) to 6 (“Strongly agree”)
to assess three primary domains: evaluation of lifestyle,
creating strategies for change and goal commitment.
Stress from diabetes was measured using the Perceived
Stress Scale (PSS), the most widely used measure of self-
reported psychological stress [19]. The PSS is a state
measure that asks about stress as experienced over the
last month. Finally, we used the Problem Areas in Dia-
betes (PAID) instrument to measure diabetes-related
emotional distress. The PAID score has been found, after
adjustment for age, diabetes duration, and general emo-
tional distress, to be a unique contributor to adherence
to self-care behaviors [20]. In addition, higher PAID
scores have been found to be associated with HbA1c in-
dependently of age, diabetes duration, general emotional
distress and adherence to self-care behaviors.
We also asked participants to rate their GH diabetes
care and their ND care on a 5-point scale, (1 = “Very
satisfied” and 5 = “Very dissatisfied”) and their per-
ceived effectiveness of GH and ND care for their dia-
betes on a 5-point scale (1 = “Very effective” and
5 = “Harmful”). Finally, participants were asked if their
ND care changed the way they thought about their dia-
betes (Yes/No/Don’t know), if they had changed any-
thing about diabetes care as a result of their ND care
(Yes/No/Don’t know), and if they believed there was
anything harmful about their ND care (Yes/No/Don’t
know). We asked for an explanation for any reports of
harm.Collection of clinical risk factor outcomes data
Laboratory tests were conducted at baseline and after
6- and 12-months for participants in the ANC cohort.
Test results for HbA1c, lipids, and blood pressure were
abstracted from the EHR for participants in our ANC
cohort, and for all patients included in the usual care
cohort. We also collected data in both cohorts on po-
tential confounders (i.e., age, gender, baseline HbA1c,
and use of sulfonylurea and/or metformin) from the
EHR.Collection of data on use of prescription medications and
utilization of medical services
EHR data were abstracted from the year prior to baseline
and during the ANC observation year in order to esti-
mate the number of new prescriptions and refills for
insulin, sulfonylureas and metformin, as well as the
number of primary care, nutrition and specialist visits
made for members of both cohorts during the same time
intervals.










% or Mean (SD)
P-valuea
Male gender (%) 60 % 54 % 0.50
Age, years 57.6 (7.6) 54.3 (8.2) 0.02
Years of diabetes
CARE at GHC
7.2 (4.2) 5.8 (4.5) 0.07
Glycemic Status
Hemoglobin A1c, % 8.0 (0.6) 8.1 (0.8) 0.56
#A1c tests in past
12 months




3.9 (1.4) 4.3 (1.3) 0.06
Total cholesterol
(mg/dl)
171.6 (36.0) 181.0 (41.2) 0.18
LDL-C (mg/dl) 89.7 (29.0) 98.1 (97.2) 0.18
HDL-C (mg/dl) 47.4 (13.3) 44.1 (11.2) 0.09
Triglycerides (mg/dl) 186.8 (118.2) 205.2 (141.2) 0.43
Blood Pressure
% ≥140/90 mmHg 22 % 33 % 0.20
% ≥130/80 mmHg 40 % 60 % 0.02
Medication Use (%)
Any 90 % 78 % 0.08
Metformin 80 % 39 % 0.002
Sulfonylureas 65 % 72 % 0.30
Other 0 % 1 % 0.62
a P-values are for chi2 comparisons of proportions or comparisons of maximum
likelihood means by unpaired, two-sided t-tests.
Bradley et al. BMC Complementary and Alternative Medicine 2012, 12:44 Page 4 of 10
http://www.biomedcentral.com/1472-6882/12/44Statistical analysis
Our data analysis plan was completely developed before
any analyses were conducted. All data were recorded in
a master database and then analyzed using SAS statistical
software version 9.2 (SAS Institute, Cary, NC). We pre-
specified our primary outcome measures for both PROs
and clinical outcomes. For PROs, we pre-specified our
primary outcome measure as the mean change in the
frequency of self-care activities captured by the Summary
of Diabetes Self-Care Activities (SDSCA) for glucose
monitoring, diet and physical activity subscales within
the ANC cohort between baseline and 6-months. For
clinical outcomes, we specified mean change in HbA1c
within the ANC cohort as our primary measure of
glycemic risk status and mean change in total choles-
terol: HDL ratio within the ANC cohort as our primary
measure of lipid risk status.
PRO results were analyzed as the change in mean
score within the ANC cohort compared by paired,
two-sided, t-tests. We used summary scores and/or
composite scales for each instrument when possible.
For the SDSCA, means were compared from three
composite scales: glucose testing, diet and physical ac-
tivity. Similarly, two composite scales were used for
the RI: lifestyle and commitment. We compared
means of composite scores for the SES, PAID and PSS
instruments. PHQ-8 results were analyzed by calculating
and comparing the change in mean score as well as the
change in the proportion of patients reaching the diag-
nostic threshold for depression (i.e., ≥10) by chi2 test
[13,14].
All EHR observations for HbA1c, lipids and blood
pressure were combined with the results from our
required laboratory testing in order to estimate the
change in each measure during the time interval from
30 days prior to baseline until 14 months after baseline
in the ANC cohort. For the usual care cohort, only the
observations in the EHR were used to estimate changes
in risk factors during the same time period. Maximum
likelihood means were calculated for each measure be-
cause they account for the intra-individual correlation in
repeat measures. Comparisons were made within the
ANC cohort by comparing means from baseline to 6- and
12-months. Comparisons between cohorts were per-
formed by generating random intercept linear regression
models for each risk factor during the observation period,
and comparing the slopes of the resulting linear estimates,
adjusting for potential confounders including age, gender,
baseline HbA1c, and use of sulfonylurea and/or metformin
at baseline. Random intercept models were applied be-
cause they allow all of the available observations to impact
the resulting linear model when the total number of obser-
vations varies between time points of interest, i.e., 6- and
12-months.For comparisons of new prescription medications, medi-
cation refills and utilization of GH services, descriptive sta-
tistics were calculated for the year prior to baseline and for
the year of ANC observation. Differences were not com-
pared statistically as they were not specified as outcome
measures, rather were calculated to provide context for any
observed changes in clinical risk that may have occurred.
Results
Forty participants (n= 40) were recruited for the ANC co-
hort and we identified three hundred twenty-nine patients
(n= 329) as a usual care cohort for comparisons. Cohort
characteristics are summarized in Table 1. Compared to
our usual care cohort, the ANC cohort was slightly older,
had a longer duration of GH care, was less likely to have
hypertension, and more likely to take metformin. The
number of HbA1c tests was also greater in the ANC co-
hort, though we believe this difference is an artifact of our
requirement to test HbA1c before enrollment.
On average, participants made 3.9 ± 2.1 ANC visits
during the 12-month observation period. Utilization of

















Any 37 (95 %) 89 %
Reinforce medication
adherence
29 (74 %) 63 %
Self-monitoring of glucose 25 (64 %) 53 %
Diet
Any 37 (95 %) 91 %
Mindful eating behavior 36 (92 %) 88 %
Increase protein 21 (54 %) 45 %
Increase vegetables 18 (46 %) 31 %
Increase fiber 17 (44 %) 28 %
Reduce dietary cholesterol/fat 11 (28 %) 16 %
Reduce sugar 10 (26 %) 14 %
Lower glycemic index 9 (23 %) 15 %
Increase PUFA 9 (23 %) 12.5 %
Lower glycemic load 7 (18 %) 10 %
Increase legumes 7 (18 %) 9 %
Increase fruit 6 (15 %) 9 %
Reduce trans fats 6 (15 %) 9 %
Increase herbs/spices 6 (15 %) 11 %
Increase soy 5 (13 %) 8 %
Increase tea 4 (10 %) 7 %
Physical Activity
Any 39 (100 %) 93 %
Walking 31 (79 %) 66 %
Aerobic 17 (44 %) 28 %
Resistance 10 (26 %) 15 %
Stress Management
Any 23 (59 %) 42 %
Deep-breathing exercises 8 (21 %) 11 %
Meditation 6 (15 %) 9 %
Yoga 4 (10 %) 7 %
Other 5 (13 %) 5 %
Dietary Supplements
Any 29 (74 %) 60 %
Omega-3 fatty acids 22 (56 %) 41 %
Chromium 18 (46 %) 26 %
Multivitamin with B-complex 17 (44 %) 23 %
Fiber 14 (36 %) 20 %
Vitamin D 10 (26 %) 13 %
Cinnamomum cassia (cinnamon) 7 (18 %) 12 %
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with 37 (93 %), 24 (60 %), 18 (45 %) and 5 (13 %) partici-
pants using ANC during the first, second, third and
fourth quarters respectively. Thirty-eight (95 %) and
thirty-three (83 %) participants completed the 6- and
12-month follow-up interviews, respectively. Thirty-three
(83 %) and nineteen (48 %) participants completed
laboratory testing at 6- and 12-months, respectively.
Table 2 summarizes the recommendations made to
participants by the ND providers according to their chart
notes. Recommendations to change self-management
practices were very common (95 % of patients received
some advice), and usually included reinforcement of
advice to monitor glucose (64 %) and to adhere to prescrip-
tion medications (74 %). Recommendations for dietary
changes, including changes to diet composition (95 %) and
behavior related to eating (92 %), were also very common.
Most participants were advised to increase physical activity
(100 %) and given specific stress management recommen-
dations (59 %). Although there was considerable overlap in
the recommendations for general categories of self-care,
and some specific recommendations (e.g., increase dietary
protein (54 %), increase vegetables (46 %) and add walking
(79 %)), many recommendations were given to small pro-
portions of participants, suggesting individualization. Fi-
nally, recommendations for dietary supplements were
common (74 %), with omega-3 fatty acids from fish being
the most common (56 %) followed by chromium (46 %),
multi-vitamin (44 %), fiber (36 %), and vitamin D3 (26 %).
Changes in patient-reported outcome measures
At 6-months, significant changes were found in most
patient-reported outcomes (Figure 1), including increased
frequency of self-care practices (i.e., glucose testing, fol-
lowing a healthy diet and physical activity), increased self-
efficacy, reduced diabetes problem areas, improved mo-
tivation for changing lifestyle and improved mood. Little
change was found in the commitment subscale of the
Readiness Index, or in the composite score of the Per-
ceived Stress Scale (P> 0.05 for both). Despite relatively
little utilization of ANC after the 6-month interview,
several significant changes persisted at the 12-month
interview, including increased glucose testing, improved
mood, increased self-efficacy, and increased motivation
for changing lifestyle.
Changes in clinical risk factors
HbA1c was significantly lower in the ANC cohort 6-months
after baseline (−0.90 %, 95 % CI: -1.64 %, -0.16 %; p=0.02)
and reductions in HbA1c favored the ANC cohort com-
pared to the usual care cohort after adjustments for age,
gender, baseline HbA1c and use of sulfonylureas and/or
metformin (Figure 2). Improvements in glycemic control
were still greater at 12-months in the ANC cohort, but the
Table 2 Summary of ANC Treatment Recommendations
(Continued)
Vitamins C and E 7 (18 %) 11 %
Probiotics 6 (15 %) 9 %
Bioflavonoid/polyphenol 6 (15 %) 8 %
Gymnema sylvestre 5 (13 %) 9 %
Coenzyme Q10 4 (10 %) 7 %
Other <4 (<10 %) <5 %
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Lipid-associated risk changed minimally in both cohorts
during the observation period (change in total cholesterol:
HDL ratio=−0.23 vs. -0.15, P=0.49 for ANC versus usual
care, adjusted for age, gender, baseline HbA1c and use of
sulfonylurea and/or metformin). Changes in other lipid and



























Mood (% reduction PHQ
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Self-efficacy (% increas
Stress (% reduction PAI
Diet (% increase SDSC
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Lifestyle (% change in R
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Figure 1 Changes in patient-reported outcomes during ANC. Results a
to the legend. P values report the results of comparisons of mean scores b
Activities; PHQ-8 = 8-question Personal Health Questionnaire; SES = Self-Effic
PSS = Perceived Stress Scale.and differences did not reach statistical significance at either
6- or 12-months (P> 0.05 for within and between cohort
changes in total cholesterol, LDL-C, HDL-C, triglycerides,
systolic and diastolic blood pressure).Changes in prescription medications and utilization of
medical services
Use of oral medications and insulin increased in the
ANC cohort during the 12-month observation period,
with three patients starting on sulfonylureas, three
patients starting on metformin and six patients starting
on basal insulin. The total number of prescription refills
also increased in the ANC cohort on average during the
observation period from 4.7 ± 2.2 per year during the
year prior to baseline compared to 5.9± 2.7 per year during
the ANC observation period, whereas refills did not change





























re reported as % change since baseline for each instrument according
y two-sided, paired t-tests. SDSCA= Summary of Diabetes Self-Care
acy Scale, PAID= Problem Areas in Diabetes; RI = Readiness Index;















ANC: Adjunctive Naturopathic Care (n=40)
UC: Usual Care (n=329)
* Adjusted for age, gender, baseline HbA1c, and use of sulfonylureas or metformin 
Change in ANC = 
-0.90% [95% CI: -1.64, -0.16], p=0.02
Change in UC =
-0.39% [95% CI: -0.80, 0.02], p=0.07
Difference* =
-0.51% [95% CI: -0.80, 0.02], p=0.07















ANC: Adjunctive Naturopathic Care (n=40)
UC: Usual Care (n=329)
Change in UC =
+0.03% [95% CI: -0.18, 0.24], p=0.24
Change in ANC = 
-0.34% [95% CI: -0.80, 0.12], p=0.12
Difference* =
-0.37% [95% CI: -0.87, 0.12], p=0.14
* Adjusted for age, gender, baseline HbA1c, and use of sulfonylureas or metformin 
Figure 2 Changes in hemoglobin A1c during ANC compared to usual care. P values for within cohort change were computed using
maximum likelihood estimates of mean HbA1c (random intercept, mixed effects model) and correspond to within cohort 2-sided t-tests; between
cohort comparisons of mean change from baseline are from the random slope and intercept mixed models (maximum likelihood, similar to
unpaired t-test of mean change over the observation period), adjusted for age, gender, baseline HbA1c and use of sulfonylureas and/or
metformin at baseline. ANC=Adjunctive Naturopathic Care, UC=Usual Care.
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observation period).
Utilization of GH primary care services increased in the
ANC cohort from 5.0± 4.5 visits/year during the year prior
to baseline to 6.5±5.6 visits/year during the observation
period. In contrast, use of primary care by members of the
usual care cohort remained unchanged, i.e., 5.5 ± 4.2 during
the year prior to baseline vs. 5.5 ± 5.4 visits/year during the
observation period. Utilization of nutrition, emergency
room and specialty care services did not change appre-
ciably in either cohort.Satisfaction, perceived benefits and effectiveness of care
Participants reported nearly equivalent satisfaction
with their ANC as with their usual GH care for dia-
betes at the 12-month interview (mean satisfaction =
2.0 ± 1.1 (ANC) and 1.8 ± 0.8 (GH)), which was virtu-
ally unchanged from their baseline report (mean satis-
faction = 2.0 ± 0.8). Participants reported their GH care
was effective for their diabetes (mean rating 1.9 ± 0.8),
with ratings of the effectiveness of ANC slightly higher,
suggesting less perceived effectiveness (2.6 ± 1.0). How-
ever, the majority of participants perceived benefit
from their ANC. At the12-month interview, 63 % of
participants reported they changed the way they think
about their diabetes as a result of their ANC and 72 %
of participants stated that they had changed their dia-
betes care as a result of their participation.Adverse effects of ANC
At 6-months, four participants attributed harm to some
element of their ANC, including two comments regarding
the high costs of dietary supplements, one comment on an
apparent increase in blood pressure, and one comment
regarding a possible adverse reaction to a dietary supple-
ment. At 12-months, only two participants attributed harm
to some element of their ANC, including a possible adverse
reaction to iron supplementation and one participant
noting feelings of guilt for not following recommendations.
Discussion
The results reported here provide the first prospectively
collected estimates of change in outcomes during and
following the delivery of ND care to people with type 2
diabetes. Provision of ANC was associated with a variety
of improvements in diabetes self-management including:
increased self-monitoring of blood glucose, improved
diet, increased physical activity, greater self-efficacy,
improved mood and reduced problem areas in diabetes.
Glucose control also improved in the ANC cohort, while
remaining unchanged in the usual care cohort. Although
we attempted to minimize confounding between groups
by performing adjusted analyses for our primary clinical
comparisons, our study was observational and therefore
these encouraging findings cannot be causally attributed
to ANC. Nevertheless, several factors suggest probable
causation. Foremost, causation is supported by the tem-
porality of the observations with the greater improvements
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i.e., the first 6-months. Secondly, the treatment recom-
mendations delivered by the NDs closely correspond to
the types of changes reported by participants. Finally, the
majority of participants reported they made self-care
changes as a result of their ANC.
Although there may have been overlap in the content of
ANC visits with that of visits to primary care providers,
diabetes educators, and nutritionists during the typical GH
care for diabetes, any benefits from the delivery of these
services to participants during the study period would
have been included in our estimates of change in both
groups.. However, even if ANC was responsible for the
improvements measured in this study, the simultaneous
increases in utilization of usual care medical services in
the ANC group make it impossible to distinguish between
direct effects of the ANC intervention and indirect effects
of ANC, which may have stimulated patient re-engagement
in their health and health care more generally.
Permanently changing behaviors is notoriously difficult
for patients. Comparable to several large clinical trials that
have tested behavior-targeted interventions, our results
suggest the greatest changes in behavior and clinical risk
occurred during the most intensive phase of the interven-
tion (months 1 through 6) and then decreased thereafter
[21-24]. Yet, unlike most previous trials, our intervention
was delivered within the context of routine care by phys-
ician-level providers and not according to a standardized
protocol. This lack of treatment standardization or inclu-
sion of special incentives for patients to adhere to a fixed
visit schedule likely resulted in lower utilization, and pos-
sibly fewer benefits, than may have occurred with a more
standardized intervention. Typical barriers for patients to
adopt longer-lasting behaviors include depression, reduced
self-efficacy and low patient motivation [15,25,26].
Therefore, the persistence in improvements in mood,
self-efficacy and motivation to change lifestyle beyond
the period of greatest utilization of ANC, , is a promising
sign that longer lasting changes in patient behaviors may
be possible through optimization of ND visit content and
frequency.
The pragmatic delivery of care, combined with collection
of patient-reported and clinical outcomes following a
CAM intervention, are unique features and considerable
strengths of the study design because they provide a
multi-faceted view of the potential real world effects of
ANC implemented within usual care in a real world
clinical setting (vs. the very structured, but often un-
translatable, components of a clinical trial protocol). In-
viting patients from a managed care setting is also a
unique feature of this study compared to past research
on ND care in diabetes because the patients were not
explicitly seeking additional care, and therefore our
results may be more generalizable than past results fromsamples of self-selecting patients [7]. However, these dif-
ferences also make it difficult to compare the changes in
HbA1c we observed in this study to those reported by
earlier evaluations of ND care. Prior retrospective
assessments of ND care reported a mean change of
−0.65 % in patients at an academic clinic [7]. However,
patients may have been more motivated to change self-
care than the participants in the current study because
they self-selected for ND care. Also, on average, the
patients included in that study completed eleven visits
over a twenty-seven month observation period com-
pared to only four visits over a twelve-month period in
the current study. A recent uncontrolled trial of a ND
nutritional program also found a reduction in HbA1c
(−0.4 %) after just 3 months [10], but this study included
a well-developed protocol in contrast to the pragmatic,
real-world approach we used in the current study. The
generally positive findings of all of the observational
studies of ND care support the need for carefully
designed randomized trials.
One important limitation in the generalizability of our
findings is the ND care in this study was applied as an
adjunct to usual care, which may have limited its bene-
fits. It remains unknown if the changes in PROs or clin-
ical risk could have been increased or extended had the
co-utilization of usual care and ND care been formally
coordinated (or “integrated”) or if ND care had been
offered as a primary care option. Because the delivery of
behavioral change counseling is infrequent in typical
primary care [27,28], very limited data are available
regarding the potential impact of an ongoing, routine
emphasis on behavioral change coupled to routine clinical
services. Future research should investigate the formal in-
tegration of usual and ND care, and extend the treatment
duration of ND care, in order to further evaluate its poten-
tial for promoting lasting behavior change.
There are several additional limitations to our study: 1)
because our study population was mainly Caucasian and
relatively well educated, the results may not apply to
regions with different demographic characteristics, 2) our
study was conducted in a managed care setting that
imposed some constraints on ND practices (e.g., NDs
could not directly order additional laboratory tests for GH
patients or prescribe medications without approval of the
patient’s GH primary care provider), and 3) because diet-
ary supplements are not covered by insurance, many parti-
cipants reported they did not use the supplements
recommended by the ND, which may have reduced the
potential clinical benefits of ANC. For example, although
the clinical effectiveness of many dietary supplements
remains unknown, omega-3 fatty acids have strong evi-
dence for improving outcomes in people with high cardio-
vascular risk and small, randomized trials suggest
chromium, cinnamon and coenzyme Q10 reduce blood
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complications of diabetes [29-33].
Based on our observations of improved glucose control,
self-care, self-efficacy, and mood plus reduced problem
areas in diabetes after initiating ANC, future research on
ANC is justified and should employ a randomized, con-
trolled trial design that permits determination of causality.
To fully evaluate the potential value of ANC, randomized
comparative effectiveness trials should compare unre-
strained, “whole-system” ANC including dietary supple-
ments and a full scope of practice with usual care.
Additional pragmatic trials should compare “best practice”
ND protocols to unconstrained ND care as it is practiced
in the community. Finally, because of the high frequency
of recommendations for dietary supplements in ND prac-
tice, and emerging evidence of potent clinical effects from
placebos [34], careful consideration is needed for how to
best evaluate the effectiveness of the highly variable dietary
supplement recommendations made by NDs in practice.
Despite the need for continued research on ND
approaches, we believe the results of this study have im-
portant implications for patients’ diabetes care, especially
for patients interested in trying ANC. Our findings suggest
numerous possible benefits and minimal risk for patients
willing to use ANC. Our findings also suggest that ANC
does not disrupt patients’ engagement in usual care and,
in fact, may increase it. Finally, the observed increases in
use of primary care services and medications for diabetes
indicate that ANC was used as a complement to usual care
and not as an alternative. These findings should be re-
assuring to usual care providers concerned that ANC may
negatively impact medical care for type 2 diabetes—our
findings suggest just the opposite.
Conclusions
Significant improvements in key diabetes health indica-
tors, including patient reported and clinical outcomes,
were found during a one-year period of adjunctive na-
turopathic care (ANC) in a cohort of patients with inad-
equately controlled type 2 diabetes. It remains unclear if
the observed improvements in self-care were responsible
for the observed reductions in clinical risk. Randomized
clinical trials are required to determine if the observed
changes were caused by exposure to ANC and to evalu-
ate the effects of ANC unconstrained by setting, cost
and scope of practice.
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